EMILIN1: A Potential Drug Target and Biomarker (G11117)

Target Name: EMILIN1

NCBI ID: G11117

EMILIN1

EMILIN1: A Potential Drug Target and Biomarker

EMILIN1, also known as EMLIN1, is a protein that is expressed in various tissues of the body, including the brain, heart, and pancreas. It is a member of the IMP family, which includes proteins involved in the intracellular signaling pathway known as the insulin/IGF-1 signaling pathway. EMLIN1 has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and survival.

EMILIN1 has also been shown to be involved in the development and progression of certain diseases, including cancer. For example, studies have shown that EMLIN1 is expressed in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, EMLIN1 has been shown to contribute to the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

As a potential drug target, EMILIN1 is being investigated for its potential utility in treating a variety of diseases. For example, studies have shown that inhibiting EMLIN1 activity can lead to the regression of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. Additionally, EMLIN1 has been shown to be involved in the regulation of insulin sensitivity, which is a key factor in the development of type 2 diabetes. As a potential drug target, this may make EMILIN1 a useful target for treating diabetes.

EMILIN1 is also being investigated as a biomarker for various diseases, including cancer and neurodegenerative diseases. For example, studies have shown that EMLIN1 is often expressed in the brains of individuals with Alzheimer's disease, and that its levels are decreased in the brains of individuals with Parkinson's disease. Additionally, EMLIN1 has been shown to be involved in the regulation of cellular processes that are important in the development of certain diseases, such as cancer. This may make EMILIN1 a useful biomarker for identifying individuals at risk for these diseases.

In conclusion, EMILIN1 is a protein that is expressed in various tissues of the body and is involved in the regulation of various cellular processes. It has also been shown to play a role in the development and progression of certain diseases, including cancer and neurodegenerative diseases. As a potential drug target and biomarker, EMILIN1 is being investigated for its potential utility in treating a variety of diseases. Further research is needed to fully understand the role of EMILIN1 in these processes and to determine its potential as a drug or biomarker.

Protein Name: Elastin Microfibril Interfacer 1

Functions: May be responsible for anchoring smooth muscle cells to elastic fibers, and may be involved not only in the formation of the elastic fiber, but also in the processes that regulate vessel assembly. Has cell adhesive capacity

The "EMILIN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EMILIN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets